FK506, transforming growth factor-β1 and mesangial matrix synthesis: Parallels and differences compared with cyclosporine A

Cytokine

Volumn 33, Issue 2, 2006, Pages 59-65

  Waiser, Johannes ^a   Dell, Kerstin ^a   Kreutzkamp, Jan ^a   Böhler, Torsten ^a   Budde, Klemens ^a   Peters, Harm ^a   Neumayer, Hans Hellmut ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

FK506; Glomerulosclerosis; Kidney transplantation; Mesangial cells; Transforming growth factor

Indexed keywords

CYCLOSPORIN A; FIBRONECTIN; MATRIX PROTEIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TSUKUBAENOLIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLOMERULOSCLEROSIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; CELLS, CULTURED; CYCLOSPORINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN-SERINE-THREONINE KINASES; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA;

EID: 33644980009     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.11.011     Document Type: Article

References (29)

1. G. Opelz Collaborative Transplant Study - 10-year report Transplant Proc 24 1992 2342 2355
2. G.A. Knoll, and R.C. Bell Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials BMJ 318 1999 1104 1107
3. D.W. Gjertson, J.M. Cecka, and P.I. Terasaki The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival Transplantation 60 1995 1384 1388
4. W.M. Bennett, A. DeMattos, M.M. Meyer, T. Andoh, and J.M. Barry Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy Kidney Int 50 1996 1089 1100
5. M.J. Mihatsch, M. Kyo, K. Morozumi, Y. Yamaguchi, V. Nickeleit, and B. Ryffel The side-effects of cyclosporine-A and tacrolimus Clin Nephrol 49 1998 356 363
6. J.M. Campistol Mechanisms of nephrotoxicity Transplantation 69 Suppl 2000 S5 S10
7. G.M. Ghiggeri, P. Altieri, R. Oleggini, J. Spada, F. Ginevri, and F. Perfumo Selective enhancement by cyclosporin A of collagen expression by mesangial cells in culture Eur J Pharm 270 1994 195 201
8. N. Perico, A. Detcheva, E.I. Khalil, and G. Remuzzi Cyclosporine induces glomerulosclerosis: Three dimensional definition of the lesions in a rat model of renal transplant Kidney Int 49 1996 1283 1288
9. S.S. Ahuja, S. Shrivastav, D. Danielpour, J.E. Balow, and D.T. Boumpas Regulation of transforming growth-factor beta 1 and its receptor by cyclosporine in human T lymphocytes Transplantation 60 1995 718 723
10. G. Wolf, F. Thaiss, and R.A.K. Stahl Cyclosporine stimulates expression of transforming growth factor β in renal cells Transplantation 60 1995 237 241
11. F.S. Shihab, T.F. Andoh, A.M. Tanner, N.A. Noble, W.A. Border, and N. Franceschini Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy Kidney Int 49 1996 1141 1151
12. S. Kaname, S. Uchida, E. Ogata, and K. Kurokawa Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells Kidney Int 42 1992 1319 1327
13. W.A. Border, S. Okuda, L.R. Languino, and E. Ruoshlahti Transforming growth factor-β regulates production of proteoglycans by mesangial cells Kidney Int 37 1990 689 695
14. F.S. Shihab, W.M. Bennett, A.M. Tanner, and T.F. Andoh Mechanism of fibrosis in experimental tacrolimus nephrotoxicity Transplantation 64 1997 1829 1837
15. A. Khanna, M. Plummer, C. Bromberek, B. Bresnahan, and S. Hariharan Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity Kidney Int 62 2002 2257 2263
16. J. Waiser, K. Dell, T. Böhler, E. Dogu, J. Gaedeke, and K. Budde Cyclosporine A up-regulates the expression of TGF-β1 and its receptors type I and type II in rat mesangial cells Nephrol Dial Transplant 17 2002 1568 1577
17. K. Budde, D.L. Coleman, J. Lacy, and R.B. Sterzel Rat mesangial cells produce granulocyte-macrophage colony-stimulating factor Am J Physiol 257 1989 F1065 F1078
18. S.I. Rennard, R. Berg, G.R. Martin, J.M. Foidart, and P.G. Robey Enzyme-linked immunoassay (ELISA) for connective tissue components Anal Biochem 104 1980 205 214
19. V.W. Armstrong, and M. Oellerich New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine Clin Biochem 34 2001 9 16
20. R.P. Kershner, and W.E. Fitzsimmons Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation Transplantation 62 1996 920 926
21. W.E. Fitzsimmons, I. Bekersky, D. Dressler, K. Raye, E. Hodosh, and Q. Mekki Demographic considerations in tacrolimus pharmacokinetics Transplant Proc 30 1998 1359 1364
22. M.L. Henry Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles Clin Transplant 13 1999 209 220
23. K. Budde, L. Fritsche, and H.H. Neumayer Differing proteinuria control with cyclosporin and tacrolimus Lancet 349 1997 330
24. I.H.H.T. Klein, A. Abrahams, T. van Ede, R.J. Hené, H.A. Koomans, and G. Ligtenberg Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects Transplantation 73 2002 732 736
25. H.H. Radeke, S. Kuster, V. Kaever, and K. Resch Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations Eur J Clin Pharmacol 44 Suppl 1 1993 S11 S16
26. G.R. Bicknell, S.T. Williams, J.A. Shaw, J.H. Pringle, P.N. Funess, and M.L. Nicholson Differential effects of cyclosporin and tacrolimus on the expression of fibrosis associated genes in isolated glomeruli from renal transplants Br J Surg 87 2000 1569 1575
27. M. Nakagawa, N. Sakamoto, N. Enomoto, Y. Tanabe, N. Kanazawa, and T. Koyama Specific inhibition of hepatitis C virus replication by cyclosporin A Biochem Biophys Res Commun 313 2004 42 47
28. F.S. Shihab, W.M. Bennett, A.M. Tanner, and T.F. Andoh Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy Kidney Int 52 1997 660 673
29. T. Goodall, C.N. Kind, and T.G. Hammond FK506-induced endothelin release by cultured rat mesangial cells J Cardiovasc Pharmacol 26 Suppl 3 1995 S482 S485